| Name | 2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid |
|---|---|
| Synonyms |
exp3174
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1 2-Butyl-4-chloro-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]imidazole-5-cboxylic acid 2-n-butyl-5-chloro-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-carboxylic acid E-3174 Lostan Cboxylic Acid Discontinued see product # L470510 Lostan Cboxylic Acid, 10 mM in DMSO EXP 3174 (LOSTAN CBOXYLIC ACID) Carboxylosartan 2-Butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid Lostan Cboxylic Acid //BP 2-BUTYL-4-CHLORO-1-[(2'-(1-H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL)METHYL]-1-H-IMIDAZOLE-5-CBOXYLIC ACID 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazole-5-cboxylic acid ’-biphenyl)-4-yl)methyl) Exp3174 LOSTAN,2-BUTYL-4-CHLORO-1-[(2'-(1-H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL)METHYL]-1-H-IMIDAZOLE-5-CBOXYLIC ACID Lostan cboxylic acid, >= 2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-cboxylic acid Lostan cboxylic acidQ: What is Lostan cboxylic acid Q: What is the CAS Number of Lostan cboxylic acid Q: What is the storage condition of Lostan cboxylic acid Q: What e the applications of Lostan cboxylic acid Lostan Cboxylic Acid 1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-cboxylic Acid 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-cboxylic acid Lostan Impurity 14 l-158641 1H-Imidazole-5-cboxylicacid, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl] 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-cboxylic Acid (Lostan Cboxylic Acid) 2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-cboxylic acid 2-Butyl-4-chloro-1-[[2(1H-tetrazol-5-yl)[1,1biphenyl]-4-yl]methyl]-1H-imidazole-5-cboxylicAcid 1H-Imidazole-5-cboxylic acid, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl) 1h-imidazole-5-cboxylicacid,2-butyl-4-chloro-1-((2’-(14-tetrazol-5-yl)(1,1 2-n-butyl-5-chloro-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazole-4-cboxylic acid Losartan carboxylic acid E-3174;EXP-3174;E 3174;EXP 3174;E3174;EXP e-3174 LOSTAN CBOXY ACID Lostan Cboxylic Acid (Lostan Cboxylate) Lostan Cboxylic Acid NEW CATALOGUE NUMBER: see product # L470510 ALSTint-A07 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-cboxylic Aci Lostan cboxylic acid in methanol 2-BUTYL-4-CHLORO-1-[(2'-(1-H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL)METHYL]-1-H-IMIDAZOLE-5-CBOXYLIC ACID //BP 1H-Imidazole-5-carboxylic acid,2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl) EXP3174 acid metabolite E-3174, EXP-3174 Lostan Cboxylic acid Impurity EXP-3174 Alistan cilexetil impurity I Lostan acid 2-Butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]imidazole-5-formic acid E-3174;EXP-3174;E 3174;EXP 3174;E3174;EXP3174;2-BUTYL-4-CHLORO-1-[[2'-(1H-TETRAZOL-5-YL)[1;1'-BIPHENYL]-4-YL]METHYL]-1H-IMIDAZOLE-5-CBOXYLIC ACID 2-Butyl-3-[[2'-(2H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-5-chloro-3H-imidazole-4-cboxylic acid 2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid |
| Description | Losartan Carboxylic Acid (E-3174), an active carboxylic acid metabolite of Losartan, is an angiotensin II receptor type 1 (AT1) antagonist. The Ki values are 0.97, 0.57, 0.67 nM for rat AT1B/AT1A and human AT1, respectively. Losartan Carboxylic Acid blocks the angiotensin II-induced responses in vascular smoothmuscle cells (VSMC). Losartan Carboxylic Acid elevates plasma renin activities and reduces mean arterial pressure[1][2][3][4]. |
|---|---|
| Related Catalog | |
| Target |
Angiotensin II receptor type 1[1] |
| In Vitro | The specific binding of [125I]-angiotensin II to VSMC is inhibited by Losartan Carboxylic Acid (E-3174) with an IC50 of 1.1 nM. Losartan Carboxylic Acid abolishes the angiotensin II-induced formation of inositolphosphates in VSMC. Losartan Carboxylic Acid inhibits the angiotensin II-induced elevation of intracellular cytosolic Ca2+ concentration with an IC50 of 5 nM. Losartan Carboxylic Acid is more effective than losartan in blocking the angiotensin II-induced increase in Egr-1 mRNA. Losartan Carboxylic Acid inhibits the angiotensin II-induced cell protein synthesis with an IC50 of 3 nM[1]. |
| In Vivo | Losartan Carboxylic Acid (E-3174) (0.1 mg/kg; i.v. followed by 0.02 mg/kg/h for 5.5 h) induces a similar level of inhibition (87±4%) of the pressor responses to angiotensin I[3]. Intravenous Losartan Carboxylic Acid (0.1 mg/kg+0.01 mg/kg/min) is infused in anesthetized dogs with recent (8.1±0.4 days) anterior myocardial infarction. Electrolytic injury of the left circumflex coronary artery to induce thrombotic occlusion and posterolateral ischemia is initiated 1 h after the start of treatment[4]. Animal Model: Mongrel dogs of either sex, weighing 15-25 kg[3] Dosage: 0.1 mg/kg (followed by 0.02 mg/kg/h) Administration: i.v. for 5.5 hours Result: The pressor response was reduced by 87±4%. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 707.8±70.0 °C at 760 mmHg |
| Melting Point | 130-132ºC |
| Molecular Formula | C22H21ClN6O2 |
| Molecular Weight | 436.894 |
| Flash Point | 381.8±35.7 °C |
| Exact Mass | 436.141449 |
| PSA | 109.58000 |
| LogP | 4.79 |
| Vapour Pressure | 0.0±2.4 mmHg at 25°C |
| Index of Refraction | 1.695 |
| Storage condition | -20°C Freezer |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Safety Phrases | 24/25 |
|---|
|
~89%
124750-92-1 |
| Literature: SHANGHAI ALLIST PHARMACEUTICAL., INC. Patent: EP1988090 A1, 2008 ; Location in patent: Page/Page column 11 ; EP 1988090 A1 |
|
~78%
124750-92-1 |
| Literature: Chen, Liqin; Li, Jian; Shen, Yingzhong Patent: US2008/90885 A1, 2008 ; Location in patent: Page/Page column 2 ; |
|
~64%
124750-92-1 |
| Literature: Tetrahedron Letters, , vol. 44, # 6 p. 1149 - 1152 |
| Precursor 2 | |
|---|---|
| DownStream 4 | |